Atherosclerotic cardiovascular disease risk profile of patients with chronic hepatitis B treated with tenofovir alafenamide or tenofovir disoproxil fumarate for 96 weeksScott Fung, Marı́a Buti, Grace Lai‐Hung Wong et al.|Alimentary Pharmacology & Therapeutics|2023Cited by 14